BIOLASE and EdgeEndo Announce FDA 510(k) Clearance of New EdgePRO Laser-Assisted Microfluidic Irrigation Device for Endodontists Jan 06, 2022 9:00am EST
BIOLASE TO PRESENT AT THE H.C. WAINWRIGHT BIOCONNECT VIRTUAL INVESTOR CONFERENCE Jan 05, 2022 8:30am EST
Nasdaq Grants BIOLASE 180-Day Extension To Meet Minimum Bid Price Requirement And Enters Into Favorable Credit Agreement Amendment Nov 23, 2021 4:19pm EST
BIOLASE To Present At The Benchmark Company Discovery One-On-One Virtual Investor Conference On December 2, 2021 Nov 23, 2021 6:30am EST
BIOLASE Reports 46% Revenue Growth In 2021 Third Quarter; Demand For Dental Lasers From New Customers Remains High And Continues To Fuel Growth Nov 10, 2021 4:05pm EST
Leading Independent Proxy Advisory Firms Glass Lewis and ISS Recommend BIOLASE Stockholders Vote "FOR" Reverse Stock Split Nov 04, 2021 4:05pm EDT